Importance In the US, approximately 10.55 million adults have atrial fibrillation (AF). AF is
associated with significantly increased risk of stroke, heart failure, myocardial infarction …

Atrial fibrillation is a major public health problem affecting 37 million people worldwide, 1
and conferring an increased risk of stroke, heart failure, myocardial infarction, and death, as …

Background Heart failure (HF) is not included in atrial fibrillation (AF) bleeding risk prediction
scores, reflecting uncertainty regarding its importance as a risk factor for major …

The heart–brain connection has long fascinated scientists for centuries with anecdotes of
people dying of a broken heart. 1 Our understanding of the complex bidirectional …

Abstract Background Direct oral anticoagulants (DOACs) reduce stroke risk in patients with
device-detected atrial fibrillation (DD-AFib) but increase major bleeding risk. The time to …

Aims Atrial fibrillation (AF) and heart failure (HF) with preserved ejection fraction (HFpEF)
are interlinked and frequently coexisting conditions. To date, patients with AF and HFpEF …

Polypharmacy (ie, treatment with≥ 5 drugs) is common in patients with atrial fibrillation (AF)
and has been associated with suboptimal management and worse outcomes. Little is known …

Background/Objectives: In Europe, the prevalence of AF is expected to increase 2.5-fold
over the next 50 years with a lifetime risk of 1 in 3–5 individuals after the age of 55 years and …

The importance of social drivers of health (SDOH) in the occurrence, detection, treatment,
and outcome of atrial fibrillation (AF) has attracted increasing attention. Addressing SDOH …

Atrial fibrillation (AF) is the most common type of chronic arrythmia, with a lifetime
prevalence of one in every three to five individuals above the age of 45 years. The higher …